Zhiqiang Li

ESR1 ligand-binding domain mutations in hormone-resistant breast cancer

Weiyi Toy, Yang Shen, Helen Won et al. · Nature Genetics · 2013 · 1.3K citations · Full text

Medicine, Molecular Biology, Oncology +9

Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway

Zhiqiang Li, Pedram Razavi, Qing Li et al. · Cancer Cell · 2018 · 521 citations · Full text

Medicine, Cancer Biology, Cell Biology +16

PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer

Ana Bosch, Zhiqiang Li, Anna Bergamaschi et al. · Science Translational Medicine · 2015 · 436 citations

Life Sciences, Molecular Biology, Oncology +17

Activating <i>ESR1</i> Mutations Differentially Affect the Efficacy of ER Antagonists

Weiyi Toy, Hazel M. Weir, Pedram Razavi et al. · Cancer Discovery · 2016 · 370 citations · Full text

Medicine, Endocrinology, Oncology +17

INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors

Qing Li, Baishan Jiang, Jiaye Guo et al. · Cancer Discovery · 2021 · 165 citations · Full text

Medicine, Molecular Biology, Oncology +14